1.Date of the shareholders’ meeting:2023/06/27
2.Important resolutions I. Profit distribution/deficit compensation: Acknowledgement of the 2022 Earning Distribution Loss Off-setting.
3.Important resolutions II. Amendments of the company charter: Resolution of amendment of the Company’s “Articles of Incorporation”.
4.Important resolutions III. Business report and financial statements: Acknowledgement of 2022 Business Report and Annual Final Accounting Ledgers and Statements.
5.Important resolutions IV. Election for directors and supervisors:
By-election for one director:
Director Yun Yen
6.Important resolutions V. Other matters:
(1)Resolution of amendment of the Company’s “Procedure for Shareholders Meetings”.
(2)Resolution of amendment of the Company’s “Procedures for Asset Acquisition & Disposal”.
(3)Resolution of amendment of the Company’s “Rules for Transaction with Related Parties, Specified Company and Group Enterprises”.
(4)Resolution to coordinate with the plan of IPO of AP Biosciences, the affiliate company, the Company shall be able to disperse its shareholding of AP Biosciences in stages.
(5)Resolution to coordinate with the plan of IPO of Obigen, the subsidiary, the Company shall be able to disperse its shareholding of Obigen in stages.
(6)Ratification of the Company’s resolution to forfeit the subscription of AP Biosciences’ 2022 cash capital increase and distribute the rights to its shareholders.
(7)Ratification of the Company’s resolution to forfeit part of subscription rights of Obigen’s 2022 cash capital increase and distribute the rights to its shareholders.
(8)Lifting of non-competition restrictions for the Company’s director.
7.Any other matters that need to be specified: None